Phenotyping for percutaneous coronary intervention and long-term recurrent weighted outcomes.
暂无分享,去创建一个
[1] M. Alasnag,et al. Baseline platelet count in percutaneous coronary intervention: a dose–response meta-analysis , 2022, Heart.
[2] H. Nouraei,et al. Comparison of Unsupervised Machine Learning Approaches for Cluster Analysis to Define Subgroups of Heart Failure with Preserved Ejection Fraction with Different Outcomes , 2022, Bioengineering.
[3] E. Hagström,et al. Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data , 2021, The Lancet.
[4] C. Lowenstein,et al. Inflammation and cardiovascular disease: From mechanisms to therapeutics , 2020, American journal of preventive cardiology.
[5] Deepak L. Bhatt,et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. , 2020, European heart journal.
[6] Marco Valgimigli,et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. , 2019, European heart journal.
[7] Alejandro Lucia,et al. Chronic inflammation in the etiology of disease across the life span , 2019, Nature Medicine.
[8] R. Diaz,et al. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. , 2019, The New England journal of medicine.
[9] M. Sathyamoorthy,et al. First and recurrent events after percutaneous coronary intervention: implications for survival analyses , 2019, Scandinavian cardiovascular journal : SCJ.
[10] Volkmar Falk,et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. , 2018, European heart journal.
[11] G. Billman,et al. Inflammation–Nature's Way to Efficiently Respond to All Types of Challenges: Implications for Understanding and Managing “the Epidemic” of Chronic Diseases , 2018, Front. Med..
[12] Kristian Thygesen,et al. Fourth Universal Definition of Myocardial Infarction (2018). , 2018, Journal of the American College of Cardiology.
[13] J. Spertus,et al. Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document , 2018, Circulation.
[14] P. Kolh,et al. [2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.] , 2018, Kardiologia polska.
[15] S. Pocock,et al. White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry) , 2017, Circulation. Cardiovascular interventions.
[16] P. Libby,et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.
[17] Lu Mao,et al. Semiparametric regression for the weighted composite endpoint of recurrent and terminal events. , 2016, Biostatistics.
[18] P. Armstrong,et al. Applying novel methods to assess clinical outcomes: insights from the TRILOGY ACS trial. , 2015, European heart journal.
[19] D. Kamat,et al. Erythrocyte sedimentation rate and C-reactive protein: how best to use them in clinical practice. , 2014, Pediatric annals.
[20] N. Frangogiannis,et al. The inflammatory response in myocardial injury, repair, and remodelling , 2014, Nature Reviews Cardiology.
[21] E. Gilardi,et al. Biomarkers in the prediction and management of acute coronary syndromes: current perspectives , 2014 .
[22] Xavier Basagaña,et al. A framework for multiple imputation in cluster analysis. , 2013, American journal of epidemiology.
[23] Marie E. Latulippe,et al. A Consideration of Biomarkers to be Used for Evaluation of Inflammation in Human Nutritional Studies , 2013, British Journal of Nutrition.
[24] J. McMurray,et al. Time to move on from 'time-to-first': should all events be included in the analysis of clinical trials? , 2012, European heart journal.
[25] Stef van Buuren,et al. MICE: Multivariate Imputation by Chained Equations in R , 2011 .
[26] Marco Valgimigli,et al. Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium , 2011, Circulation.
[27] Henri Luchian,et al. A unifying criterion for unsupervised clustering and feature selection , 2011, Pattern Recognit..
[28] L. Newby,et al. Documented traditional cardiovascular risk factors and mortality in non-ST-segment elevation myocardial infarction. , 2007, American heart journal.
[29] Virginie Rondeau,et al. Joint frailty models for recurring events and death using maximum penalized likelihood estimation: application on cancer events. , 2006 .